Search Results - "SCHERER, LYNN W."

Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin by Jalaludin, Muhammad Yazid, Deeb, Asma, Zeitler, Philip, Garcia, Raymundo, Newfield, Ron S., Samoilova, Yulia, Rosario, Carmen A., Shehadeh, Naim, Saha, Chandan K., Zhang, Yilong, Zilli, Martina, Scherer, Lynn W., Lam, Raymond L. H., Golm, Gregory T., Engel, Samuel S., Kaufman, Keith D., Shankar, R. Ravi

“…Objective To assess the efficacy and safety of sitagliptin in youth with type 2 diabetes (T2D) inadequately controlled with metformin ± insulin. Study Design…”
Get full text

897-P: Demographic and Glycemic Parameters in Global Populations of Younger vs. Older Youth with T2D Randomized in Clinical Trials of Sitagliptin by NEWFIELD, RON S., DEEB, ASMA, JALALUDIN, MUHAMMAD Y., GARCIA, RAYMUNDO, SAMOILOVA, YULIA, ROSARIO, CARMEN A., SHEHADEH, NAIM, SAHA, CHANDAN K., ZHANG, YILONG, XU, ZHI JIN, SCHERER, LYNN W., ENGEL, SAMUEL S., KAUFMAN, KEITH D., ZEITLER, PHILIP, SHANKAR, R. RAVI

“…Objectives: To compare the characteristics of younger (Y, 10-14 yrs) vs. older (O, 15-17 yrs) patients (pts) with T2D in global clinical trials of sitagliptin…”
Get full text

896-P: Demographic and Glycemic Parameters across Global Regions in Youth with T2D in Clinical Trials of Sitagliptin by JALALUDIN, MUHAMMAD Y., DEEB, ASMA, ZEITLER, PHILIP, GARCIA, RAYMUNDO, NEWFIELD, RON S., SAMOILOVA, YULIA, ROSARIO, CARMEN A., SHEHADEH, NAIM, SAHA, CHANDAN K., ZHANG, YILONG, XU, ZHI JIN, SCHERER, LYNN W., ENGEL, SAMUEL S., KAUFMAN, KEITH D., SHANKAR, R. RAVI

“…Objectives: To compare baseline characteristics of 10-17 yr old patients (pts) with T2D from different regions in clinical trials of sitagliptin as initial…”
Get full text

A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes by Shankar, R. Ravi, Zeitler, Philip, Deeb, Asma, Jalaludin, Muhammad Yazid, Garcia, Raymundo, Newfield, Ron S., Samoilova, Yulia, Rosario, Carmen A., Shehadeh, Naim, Saha, Chandan K., Zhang, Yilong, Zilli, Martina, Scherer, Lynn W., Lam, Raymond L. H., Golm, Gregory T., Engel, Samuel S., Kaufman, Keith D.

“…Objective To assess the efficacy and safety of DPP‐4 inhibition with sitagliptin in youth with type 2 diabetes (T2D). Study Design This was a 54‐week,…”
Get full text

2335-PUB: Clinical Trial of the Use of Sitagliptin in Pediatric Patients with T2D: Baseline Characteristics by JALALUDIN, MUHAMMAD Y., GARCIA, RAYMUNDO, NEWFIELD, RON S., ROSARIO, CARMEN A., SAMOILOVA, YULIA, SHEHADEH, NAIM, ZHANG, YILONG, SCHERER, LYNN W., SAHA, CHANDAN K., ENGEL, SAMUEL S., ZEITLER, PHILIP, KAUFMAN, KEITH D., SHANKAR, R. RAVI

“…MK-0431-P083, a multinational, 54-week, phase III study of the DPP-4 inhibitor sitagliptin (SITA) as initial oral therapy in patients 10-17 years of age with…”
Get full text